Pharmaceuticals - Union Register


Register of orphan medicinal products


Product information


EU orphan designation number: EU/3/08/558   
Active ingredient: Sapacitabine
Indication: Treatment of acute myeloid leukaemia
Sponsor: Cyclacel Limited
Dundee Technopole, James Lindsay Place, Dundee DD1 5JJ, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
14/07/2008 Orphan designation EMEA/OD/015/08 (2008)3657 of 10/07/2008